What does the future hold for Vicarious Surgical Inc (RBOT) Stock?
Piper Sandler lowered the price target for the Vicarious Surgical Inc (NYSE:RBOT) stock from “an Overweight” to “a Neutral”. The rating was released on March 04, 2022, according to finviz. The research report from Cowen has initiated the stock to Outperform, with a price target set at $15. The stock was initiated by Canaccord Genuity, […]
